PT - JOURNAL ARTICLE AU - Michael J. Plank AU - Alex James AU - Audrey Lustig AU - Nicholas Steyn AU - Rachelle N Binny AU - Shaun C. Hendy TI - Potential reduction in transmission of COVID-19 by digital contact tracing systems: a modelling study AID - 10.1101/2020.08.27.20068346 DP - 2021 Jan 01 TA - medRxiv PG - 2020.08.27.20068346 4099 - http://medrxiv.org/content/early/2021/11/02/2020.08.27.20068346.short 4100 - http://medrxiv.org/content/early/2021/11/02/2020.08.27.20068346.full AB - Background Digital tools are being developed to support contact tracing as part of the global effort to control the spread of COVID-19. These include smartphone apps, Bluetooth-based proximity detection, location tracking, and automatic exposure notification features. Evidence on the effectiveness of alternative approaches to digital contact tracing is so far limited.Methods We use an age-structured branching process model of the transmission of COVID-19 in different settings to estimate the potential of manual contact tracing and digital tracing systems to help control the epidemic. We investigate the effect of the uptake rate and proportion of contacts recorded by the digital system on key model outputs: the effective reproduction number, the mean outbreak size after 30 days, and the probability of elimination.Results Effective manual contact tracing can reduce the effective reproduction number from 2.4 to around 1.5. The addition of a digital tracing system with a high uptake rate over 75% could further reduce the effective reproduction number to around 1.1. Fully automated digital tracing without manual contact tracing is predicted to be much less effective.Conclusions For digital tracing systems to make a significant contribution to the control of COVID-19, they need be designed in close conjunction with public health agencies to support and complement manual contact tracing by trained professionals.Competing Interest StatementThe research was funded by the New Zealand Ministry of Business, Innovation and Employment (MBIE) and Te Pūnaha Matatini, New Zealand's Centre of Research Excellence in Complex Systems.Funding StatementThe research was funded by the New Zealand Ministry of Business, Innovation and Employment (MBIE) and Te Pūnaha Matatini, New Zealand's Centre of Research Excellence in Complex Systems.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo new data is presented in this manuscript